Past Work
Sample activations & results.
Challenge
Communicate a leading COVID-19 vaccine through Phase 3 readouts and major FDA and EMA milestones during the pandemic, while navigating fast-moving safety scrutiny and adverse event headlines alongside global access and executive communications needs.
Strategy
Built a global messaging framework and rapid response playbook, aligned medical, regulatory, and legal stakeholders, prepared spokespeople and executive communications, and tailored COVAX access narratives for Africa and other low-resource markets to maintain clarity, consistency, and trust.
Impact
-
Secured top-tier national and trade coverage elevating competitive share of voice in COVID-19, HIV, RSV, and infectious disease conversations
-
Clinical trial campaign drove 2K+ direct clicks to enrollment pages
-
Disease awareness campaign reached 2M+ audience and generated 130K+ clicks within three weeks
-
Congress activation delivered 895K impressions and 441K video views, exceeding internal benchmarks
-
Major U.S. campus launch generated 40M+ media impressions and 8K+ employee engagement views
Global Biopharmaceutical Company
Fortune 50 Healthcare Organization
Challenge
Elevate corporate reputation and executive visibility in a highly scrutinized healthcare affordability landscape while shaping national conversations around GLP-1 access, insurance complexity, and prescription pricing.
Strategy
Developed and executed an enterprise strategy designed to shift the company from transactional savings brand to trusted healthcare authority. Identified high-impact policy and market inflection points, built proactive initiatives to shape media narratives, and positioned executives as credible voices in national conversations.
Impact
-
Doubled corporate share of voice (23% → 56%)
-
Increased corporate story volume by 67% year over year
-
Secured consistent tier-one coverage across Axios, Barron's, Bloomberg, Fortune, Reuters, and Wall Street Journal
-
Elevated executives as authoritative voices, earning direct quotes in 27% of total coverage
-
Shifted research strategy from primarily organic pickup (26%) to majority proactive placements (~60%), positioning the company as a national authority on prescription affordability and healthcare access
National Prescription Savings Platform
Corporate, B2B, Consumer
Challenge
Establish the company’s first formal, strategic communications program ahead of Phase 3 data milestones and initial FDA filing, while positioning a first-in-class therapy as a credible leader in a competitive rare disease landscape with a limited budget and minimal media footprint.
Strategy
Built the communications function from the ground up, defining narrative architecture, strategic pillars, spokesperson positioning, and milestone-driven activation plans. Centered the program on expanding awareness of unmet patient need, elevating clinical data milestones, and positioning leadership as category authorities in liver disease. Integrated messaging across investor, media, and medical congress audiences to create a cohesive market presence ahead of regulatory submission.
Impact
-
Increased share of voice by 61% year over year versus key competitors
-
Achieved 62M earned media reach in year one
-
Drove 8x increase in unique media coverage year over year
-
Positioned the company as a recognized leader in disease state prior to FDA filing
-
Strengthened market visibility leading to $4.3B acquisition by a global biopharma company
Clinical-Stage Biopharmaceutical Company
From Data Readout to FDA Approval
National Fertility Awareness Campaign
White Label Influencer Marketing
Challenge
Support the launch and amplification of a consumer-facing fertility awareness campaign on behalf of a pharmaceutical client, while navigating regulatory complexity, sensitive subject matter, and the need for authentic, stigma-reducing storytelling. The goal was to elevate national conversation around infertility, expand reach beyond traditional pharma channels, and reduce IVF misinformation among consumers.
Strategy
Defined a consumer-first strategy leveraging influencer engagement to bring fertility conversations into mainstream culture. Centered the campaign on authentic patient and provider storytelling to reposition infertility as a widely shared health issue rather than a niche medical topic, using long-form documentary storytelling as the narrative anchor to humanize the experience and expand reach beyond traditional healthcare channels. Designed the campaign to intersect with platforms and media ecosystems—including entry into SXSW—while ensuring all storytelling remained compliant within pharmaceutical regulatory frameworks without sacrificing authenticity.
Impact
-
Achieved highest-ever engagement rate (8.02%) on content driving to campaign homepage and sign-up page
-
Grew organic brand mentions 150% year over year across social media platforms
-
Generated record-setting engagements through influencer partnerships, with content outperforming industry benchmarks by 75%
-
Launched original docuseries that drove a nearly 400% increase in YouTube subscriber growth within three weeks
-
Outperformed industry engagement benchmarks across all platforms, with co-created content averaging 4.5% engagement versus 2-3% industry strandard.
Challenge
Transition a niche, founder-led ambulatory surgery center (ASC) technology startup into an enterprise-ready market leader following private equity acquisition. Strengthen brand credibility in a regulated healthcare IT market, clarify differentiation against hospital-centric competitors, and support strategic growth initiatives including M&A.
Strategy
Defined and executed a narrative shift to support the company’s transition from founder-led startup to private equity–backed growth platform, anchoring the strategy in a clear value proposition: ambulatory surgery centers require technology purpose-built for their workflows, not adapted from hospital systems. Repositioned the brand around enterprise value creation, emphasizing operational ROI, regulatory readiness, scalability, and long-term modernization over product features, while leveraging the founder’s long-standing innovation leadership as a strategic asset.
Impact
-
Expanded market visibility and competitive authority, achieving 83.2 million in trailing 30-day audience reach (vs. 8.2 million for the primary competitor)
-
Aligned all communications with private equity growth objectives to reinforce valuation drivers, acquisition integration, and sustained category leadership.
-
Drove sustained executive visibility and measurable social engagement across priority channels
-
Supported sustained company growth and recognition, including three consecutive years on the Inc. 5000 list and regional fastest-growing private company honors
Ambulatory Surgery Center Technology Platform
Health Tech Private Equity-Backed Growth
Challenge
Build public and legislative support to secure Medicaid reimbursement and increased state funding for a home visiting program serving first-time mothers and infants.
Strategy
Developed a unified narrative and media strategy to elevate the program’s value amid competing healthcare priorities. Integrated media relations, spokesperson training, opinion placements, and targeted outreach in key legislative districts to shape public perception and influence policymakers.
Impact
-
Secured sustained earned coverage across priority legislative districts during budget negotiations
-
Trained advocates and program participants to humanize the policy debate and strengthen message consistency
-
Integrated earned media into direct legislative outreach, reinforcing funding arguments with public validation
-
Contributed to successful inclusion of $90.3M in permanent state funding and $46M in new state investment, expanding access to home visiting programs for new, vulnerable mothers statewide
Public Health Nonprofit
Maternal & Child Health Advocacy
Let's CONNECT
© 2026 Northbound Communications. All rights reserved.